Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
出版年份 2017 全文链接
标题
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
作者
关键词
-
出版物
EUROPEAN HEART JOURNAL
Volume 39, Issue 16, Pages 1446-1455
出版商
Oxford University Press (OUP)
发表日期
2017-06-26
DOI
10.1093/eurheartj/ehx394
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias
- (2017) Massimiliano Gnecchi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The KCNH2 -IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2
- (2017) Manuela Mura et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Calcium Revisited
- (2016) John R. Giudicessi et al. Circulation-Arrhythmia and Electrophysiology
- Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
- (2016) Emma D. Deeks DRUGS
- Correctors of mutant CFTR enhance subcortical cAMP–PKA signaling through modulating ezrin phosphorylation and cytoskeleton organization
- (2016) Anna C. Abbattiscianni et al. JOURNAL OF CELL SCIENCE
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- (2015) Silvia G. Priori et al. EUROPEAN HEART JOURNAL
- Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny
- (2014) Ashish Mehta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
- (2014) Ashish Mehta et al. CARDIOVASCULAR RESEARCH
- Hyperphosphorylation of RyRs Underlies Triggered Activity in Transgenic Rabbit Model of LQT2 Syndrome
- (2014) Dmitry Terentyev et al. CIRCULATION RESEARCH
- Cardiac sympathetic denervation to prevent life-threatening arrhythmias
- (2014) Peter J. Schwartz Nature Reviews Cardiology
- Calcium release microdomains and mitochondria
- (2013) Michael Kohlhaas et al. CARDIOVASCULAR RESEARCH
- The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy
- (2013) P. J. Schwartz et al. EUROPEAN HEART JOURNAL
- Integrins protect cardiomyocytes from ischemia/reperfusion injury
- (2013) Hideshi Okada et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of Genetics on the Clinical Management of Channelopathies
- (2013) Peter J. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-QT Syndrome
- (2012) Peter J. Schwartz et al. Circulation-Arrhythmia and Electrophysiology
- Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell–Derived Human Cardiomyocytes
- (2012) Ashish Mehta et al. TOXICOLOGICAL SCIENCES
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?
- (2010) Peter J. Schwartz et al. CIRCULATION
- Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
- (2010) Alessandra Moretti et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started